Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Ra Pharmaceuticals (RARX) News Today

Ra Pharmaceuticals logo
RA: Discount Continues To Leave Some Opportunity
RARX_old Historical Data
Get Ra Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RARX and its competitors with MarketBeat's FREE daily newsletter.

Let’s be blunt (Ad)

Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

Check out the $100 Challenge now

RARX Media Mentions By Week

RARX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RARX
News Sentiment

0.00

0.48

Average
Medical
News Sentiment

RARX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RARX Articles
This Week

0

0

RARX Articles
Average Week

Get Ra Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RARX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:RARX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners